Finance

Lists
WST:NYSE
West Pharmaceutical Services Inc
349,42 US$
0,00%
(0,00) 1D
14 აგვ, 16:01:55 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WST...
Mkt. cap
24,59 მლრდ.
Avg. vol.
740,18 ათ.
Volume
87,00
Dividend
0,25%
Quarterly dividend
0,22 US$
Ex-dividend date
29 ივლ. 2026
P/E ratio
44,67
52-wk high
386,00 US$
52-wk low
223,83 US$
EPS
7,82 US$
Beta
1,15
Shares outstanding
70,38 მლნ.
No. of employees
11 ათ.
Mkt. cap
24,59 მლრდ.
Avg. vol.
740,18 ათ.
Volume
87,00
Dividend
0,25%
Quarterly dividend
0,22 US$
Ex-dividend date
29 ივლ. 2026
P/E ratio
44,67
52-wk high
386,00 US$
52-wk low
223,83 US$
EPS
7,82 US$
Beta
1,15
Shares outstanding
70,38 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
Profile
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. Wikipedia
About West Pharmaceutical Services Inc
CEOერიკ ემ გრინ
Employees10,8 ათ.
Founded1923
HeadquartersWest Whiteland Township, პენსილვანია, ამერიკის შეერთებული შტატები
SectorHealth care
Websitewestpharma.com
Analyst ratings
Based on 10 analysts giving stock ratings to WST in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for WST in the last 3 months.
Highest
Current 349,42 US$
447,00 US$ (+27,93%)
Average
403,78 US$ (+15,56%)
Lowest
365,00 US$ (+4,46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanne Wuensch
Citi
Buy
Maintained
412,00 US$
+17,9%
08/03/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
425,00 US$
+21,6%
07/27/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
410,00 US$
+17,3%
07/24/2026
Luke Sergott
Barclays
Buy
Maintained
400,00 US$
+14,5%
07/24/2026
Brendan Smith
TD Cowen
Buy
Reiterated
410,00 US$
+17,3%
07/23/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/23/2026
Curtis Moiles
Exane BNP Paribas
Buy
Initiated
447,00 US$
+27,9%
07/13/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
365,00 US$
+4,5%
07/09/2026
Paul Knight
KeyBanc
Buy
Maintained
390,00 US$
+11,6%
07/02/2026
Michael Polark
Wolfe Research
Buy
Reiterated
375,00 US$
+7,3%
06/01/2026
Patrick B Donnelly
Citi
Buy
Maintained
400,00 US$
+14,5%
04/24/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
-
-
04/23/2026
Dan Leonard
UBS
Buy
Maintained
340,00 US$
-2,7%
02/13/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
315,00 US$
-9,9%
02/13/2026
David Windley
Jefferies
Buy
Maintained
295,00 US$
-15,6%
02/10/2026
Nico Chen
DBS
Buy
Maintained
320,00 US$
-8,4%
01/28/2026
Last report
23 ივლ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
2,37 US$ / 2,08 US$
+13,86%beat
Revenue / Est. (USD)
872,30 მლნ. / 839,98 მლნ.
+3,85%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
804,60 მლნ.
805,00 მლნ.
844,90 მლნ.
872,30 მლნ.
Cost of goods sold
510,30 მლნ.
501,10 მლნ.
548,50 მლნ.
543,10 მლნ.
Cost of revenue
510,30 მლნ.
501,10 მლნ.
548,50 მლნ.
543,10 მლნ.
Research and development expenses
17,10 მლნ.
21,80 მლნ.
15,80 მლნ.
19,70 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101,10 მლნ.
107,50 მლნ.
99,50 მლნ.
112,00 მლნ.
Operating expense
118,50 მლნ.
129,70 მლნ.
113,10 მლნ.
133,20 მლნ.
Total operating expenses
628,80 მლნ.
630,80 მლნ.
661,60 მლნ.
676,30 მლნ.
Operating income
175,80 მლნ.
174,20 მლნ.
183,30 მლნ.
196,00 მლნ.
Other non operating income
-200,00 ათ.
600,00 ათ.
-200,00 ათ.
-200,00 ათ.
EBT including unusual items
174,00 მლნ.
165,40 მლნ.
183,50 მლნ.
186,20 მლნ.
EBT excluding unusual items
179,50 მლნ.
181,20 მლნ.
188,60 მლნ.
201,20 მლნ.
Income tax expense
34,00 მლნ.
33,30 მლნ.
44,70 მლნ.
32,20 მლნ.
Effective tax rate
19,54%
20,13%
24,36%
17,29%
Other operating expenses
300,00 ათ.
400,00 ათ.
-2,20 მლნ.
1,50 მლნ.
Net income
140,00 მლნ.
132,10 მლნ.
138,80 მლნ.
154,00 მლნ.
Net profit margin
17,40%
16,41%
16,43%
17,65%
Earnings per share
1,96
2,04
2,13
2,37
Interest and investment income
4,70 მლნ.
5,30 მლნ.
5,10 მლნ.
3,80 მლნ.
Interest expense
-200,00 ათ.
-
-1,90 მლნ.
-2,60 მლნ.
Net interest expenses
4,50 მლნ.
5,30 მლნ.
3,20 მლნ.
1,20 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
218,80 მლნ.
221,20 მლნ.
228,50 მლნ.
242,20 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები